The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer

Objective: To investigate whether albumin-bilirubin score can be used as a prognostic marker in pancreatic cancer patients post-surgery. Method: The retrospective study was conducted at the Medical Oncology Clinic, Karadeniz Technical University, Trabzon, Turkey, and comprised data from 2010 to 2018...

Full description

Bibliographic Details
Main Authors: Cekic, A.B (Author), Fidan, E. (Author), Fidan, S. (Author), Kazaz, N. (Author), Yildirim, A. (Author)
Format: Article
Language:English
Published: Pakistan Medical Association 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03907nam a2200685Ia 4500
001 10.47391-JPMA.2413
008 220630s2022 CNT 000 0 und d
020 |a 00309982 (ISSN) 
245 1 0 |a The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer 
260 0 |b Pakistan Medical Association  |c 2022 
520 3 |a Objective: To investigate whether albumin-bilirubin score can be used as a prognostic marker in pancreatic cancer patients post-surgery. Method: The retrospective study was conducted at the Medical Oncology Clinic, Karadeniz Technical University, Trabzon, Turkey, and comprised data from 2010 to 2018 of pancreatic cancer patients who had undergone distal pancreatectomy or pancreaticoduodenectomy and were followed up for 3 years. Preoperative and postoperative serum albumin, carcinoembryonic antigen, carbohydrate antigen 19-9, bilirubin, neutrophil: lymphocyte ratio and platelet: lymphocyte ratio were compared as inflammation markers, while albumin-bilirubin scores were calculated using the equation linear predictor. Data was analysed using SPSS 17. Results: Of the 39 patients, 23(59%) were men and 16(41%) were women. The mean age of the sample was 62.4±10.2 years. No statistically significant changes were observed between preoperative and postoperative albumin-bilirubin scores, carcinoembryonic antigen, neutrophil: lymphocyte ratio and platelet: lymphocyte ratio (p>0.05). Significant decreases were observed in postoperative carbohydrate antigen 19-9, aspartate transaminase and alanine transaminas levels (respectively<0.05). No significant change was determined in postoperative albumin-bilirubin grade distributions compared to preoperative values (p=0.180). Although the rate of recurrence increased in line with preoperative albumin-bilirubin scores, the finding was not statistically significant (p=0.055). Mortality rate increased significantly in line with preoperative albumin-bilirubin scores (p=0.013). Conclusion: The albumin-bilirubin score affected survival in patients with pancreatic cancer, and can be employed as a prognostic factor in this patient group. © 2022 Pakistan Medical Association. All rights reserved. 
650 0 4 |a adult 
650 0 4 |a alanine aminotransferase 
650 0 4 |a albumin bilirubin score 
650 0 4 |a albumin blood level 
650 0 4 |a Albumin-bilirubin score 
650 0 4 |a Article 
650 0 4 |a aspartate aminotransferase 
650 0 4 |a bilirubin blood level 
650 0 4 |a CA 19-9 antigen 
650 0 4 |a cancer grading 
650 0 4 |a cancer prognosis 
650 0 4 |a cancer recurrence 
650 0 4 |a cancer staging 
650 0 4 |a carcinoembryonic antigen 
650 0 4 |a comparative study 
650 0 4 |a demographics 
650 0 4 |a distal pancreatectomy 
650 0 4 |a female 
650 0 4 |a follow up 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a inflammation 
650 0 4 |a lymph node dissection 
650 0 4 |a lymph node metastasis 
650 0 4 |a male 
650 0 4 |a middle aged 
650 0 4 |a neutrophil lymphocyte ratio 
650 0 4 |a pancreas adenocarcinoma 
650 0 4 |a pancreas cancer 
650 0 4 |a Pancreatic cancer 
650 0 4 |a pancreaticoduodenectomy 
650 0 4 |a pathology 
650 0 4 |a platelet lymphocyte ratio 
650 0 4 |a postoperative care 
650 0 4 |a preoperative evaluation 
650 0 4 |a Prognostic factors 
650 0 4 |a retrospective study 
650 0 4 |a scoring system 
650 0 4 |a statistical analysis 
650 0 4 |a surgical margin 
650 0 4 |a survival analysis 
650 0 4 |a Turkey (republic) 
700 1 0 |a Cekic, A.B.  |e author 
700 1 0 |a Fidan, E.  |e author 
700 1 0 |a Fidan, S.  |e author 
700 1 0 |a Kazaz, N.  |e author 
700 1 0 |a Yildirim, A.  |e author 
773 |t Journal of the Pakistan Medical Association 
856 |z View Fulltext in Publisher  |u https://doi.org/10.47391/JPMA.2413